Neogen’s GeneQuence assays for Salmonella, Listeria, and L. monocytogenes combine the superior specificity of DNA hybridization technology with the ability to rapidly process a few samples, or up to 372 samples at once.
Neogen’s Reveal line of lateral flow microbial tests for E. coli O157:H7,
Salmonella and Listeria allows users to quickly and accurately screen samples
for these pathogens. Reveal for E. coli O157:H7 utilizes Neogen’s proprietary
media to allow users to screen samples for this pathogen in as little as 8 hours.
For more information visit www.neogen.com.
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer